Craniectomy for Aximium Aneurysm Treatment: Relieving Pressure, Saving Lives | My Medic Plus — Cost, Top Hospitals & Success Rates | MyMedicPlus

Craniectomy for intracranial aneurysm treatment is a major cerebrovascular neurosurgical procedure in which the skull is opened to gain direct access to an aneurysm — an abnormal balloon-like dilation of an arterial wall within the brain. Unlike a standard craniotomy (where the bone flap is replaced at the end of surgery), a craniectomy may be performed as the primary or secondary approach when significant brain swelling is anticipated or encountered, leaving the bone out temporarily to prevent fatal intracranial pressure elevation.

The most common aneurysm locations approached via open craniectomy or craniotomy include the anterior communicating artery (AComA), posterior communicating artery (PComA), middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA), and basilar artery tip. The surgical objective is to place a metallic clip across the aneurysm neck — isolating the sac from the parent circulation while preserving flow in all adjacent arteries. If the aneurysm has ruptured, causing subarachnoid haemorrhage (SAH), the surgery is typically performed within 24–72 hours to prevent re-bleeding.

Intraoperative neurophysiological monitoring (IONM) — including EEG, motor- and somatosensory-evoked potentials, and indocyanine green (ICG) videoangiography — is routinely used during complex aneurysm clipping to reduce the risk of inadvertent vessel injury. Temporary clips may be applied to the parent artery to reduce aneurysm turgor during dissection, and intraoperative Doppler ultrasound or fluorescence angiography confirms clip placement accuracy.

For patients with ruptured aneurysms complicated by massive intracerebral or intraventricular haemorrhage, decompressive craniectomy — removing a larger bone flap — may be performed simultaneously to manage the inevitable brain swelling. Leading neurosurgical centres in India, South Korea, and Turkey perform high-volume intracranial aneurysm surgery with outcomes comparable to leading Western centres at substantially lower cost.

The primary condition treated by craniectomy/craniotomy with aneurysm clipping is ruptured intracranial aneurysm with subarachnoid haemorrhage (SAH). SAH presents as a sudden catastrophic 'thunderclap' headache and carries an initial mortality of approximately 35%; re-bleeding within 24 hours increases mortality by a further 40–50%, making early surgical or endovascular securing of the aneurysm a neurosurgical emergency. World Federation of Neurosurgical Societies (WFNS) grades I–III are generally candidates for early clipping or coiling, while grades IV–V are managed selectively.

Unruptured intracranial aneurysms detected incidentally on brain imaging are treated prophylactically when they meet criteria for high rupture risk: size greater than 7 mm, posterior circulation location, irregular or multilobulated shape, presence of a daughter sac, or familial aneurysm history. The ISUIA (International Study of Unruptured Intracranial Aneurysms) provides the primary evidence base for risk-benefit calculations. Complex or giant aneurysms (>25 mm), those with broad necks or unfavourable anatomy for endovascular coiling, and aneurysms causing mass effect on adjacent cranial nerves are best addressed with open surgical clipping.

Candidates for open surgical clipping via craniectomy or craniotomy include patients with confirmed intracranial aneurysm — ruptured or unruptured — whose anatomy is not amenable to endovascular coiling or flow diversion, or where open surgery offers superior durability and occlusion rates. The ideal surgical candidate is medically fit, under 70 years of age, with a ruptured aneurysm of WFNS grade I–III or an unruptured aneurysm with high rupture-risk features. Pre-operative CTA (CT angiography) or DSA (digital subtraction angiography) confirms aneurysm morphology, neck width, dome-to-neck ratio, and relationship to parent vessels.

Contraindications to open surgery include very poor neurological grade (WFNS IV–V) in patients with pre-existing co-morbidities suggesting poor recovery potential, severe systemic illness precluding anaesthesia, and giant or fusiform aneurysms where endovascular treatment (pipeline embolisation device, flow diverter) is feasible and safer. Endovascular coiling has replaced open clipping as first-line therapy for most ruptured aneurysms at centres with experienced interventional neuroradiologists, based on the ISAT trial showing lower morbidity and mortality with coiling; however, clipping remains superior for durability and for MCA and AComA aneurysms with complex anatomy.

The primary surgical approach is determined by aneurysm location. Anterior circulation aneurysms (AComA, PComA, ICA, MCA) are approached via a pterional (frontotemporal) craniotomy/craniectomy — the workhorse approach in cerebrovascular neurosurgery. Posterior circulation aneurysms (basilar, posterior inferior cerebellar artery) require far-lateral, retrosigmoid, or subtemporal approaches. Supraorbital 'eyebrow' keyhole craniotomy is increasingly used for selected anterior circulation aneurysms, offering reduced morbidity and cosmetic advantage.

When significant brain oedema is anticipated — particularly in high-grade SAH with intracerebral haematoma — the bone flap may be left out (decompressive craniectomy) rather than replaced at the end of surgery. In this scenario, cranioplasty is performed 3–6 months later after neurological stabilisation. Adjunct techniques include bypass surgery (STA-MCA or STA-PCA bypass) for complex giant aneurysms requiring parent artery occlusion, and endoscope-assisted clipping for aneurysms in anatomically confined spaces. For multiple aneurysms, staged procedures or simultaneous bilateral craniotomies may be planned, guided by which aneurysm ruptured (the 'culprit' lesion). The treating surgeon individualises the chosen technique based on patient anatomy, the extent and nature of the underlying condition, available equipment, and the balance of procedural benefit against risk — a decision made in consultation with the patient following a thorough informed consent discussion covering all available options.

Microsurgical aneurysm clipping achieves complete aneurysm occlusion in 95–99% of cases, with extremely low rates of long-term recurrence — the primary advantage over endovascular coiling, which carries a 20–33% recanalization rate requiring re-treatment. The ISAT trial demonstrated that among patients where both modalities are feasible, coiling offers better short-term outcomes, but long-term follow-up shows comparable outcomes for rupture prevention. For complex and giant aneurysms not amenable to coiling, clipping remains the gold standard with occlusion rates exceeding 95%.

For ruptured aneurysm surgery, early intervention (within 24–72 hours) prevents re-bleeding and allows intra-operative washout of cisternal blood — reducing the risk of cerebral vasospasm, a major cause of delayed neurological deficit (occurring in 30–70% of SAH patients around days 4–14). Overall, favourable neurological outcomes (modified Rankin Scale 0–2) are achieved in 60–75% of WFNS grade I–II SAH patients who undergo successful clipping. For unruptured aneurysm surgery in experienced hands, morbidity is less than 3% and mortality under 1% for anterior circulation lesions.

Open aneurysm surgery carries specific neurovascular risks. Intraoperative aneurysm rupture — premature bleeding before the clip is placed — occurs in 5–20% of surgeries for ruptured aneurysms and significantly increases the risk of a poor neurological outcome. Inadvertent occlusion of parent vessels or perforating arteries during clip application can cause ischaemic stroke (1–5%), sometimes not apparent until postoperative imaging. Cranial nerve injury — particularly oculomotor nerve palsy (III nerve) with posterior communicating artery aneurysms — may manifest as ptosis and double vision, usually partially or fully reversible.

Post-operative complications include cerebral vasospasm (30–70%) causing delayed ischaemic neurological deficits between days 4 and 14, hydrocephalus requiring ventriculoperitoneal shunting (15–20%), cerebral oedema, seizures (5–10%), deep vein thrombosis, and pulmonary embolism. Wound complications, meningitis, and CSF leak are less common (1–3%). Incomplete clipping — where a residual aneurysm neck remains — requires re-operation or adjunct endovascular treatment and occurs in 3–8% of cases, highlighting the importance of intraoperative angiographic confirmation of clip placement.

After aneurysm clipping, patients are managed in the neurological ICU with close monitoring for vasospasm — guided by transcranial Doppler (TCD) ultrasonography and CT perfusion imaging. Triple-H therapy (hypertension, haemodilution, hypervolaemia) or induced hypertension with calcium channel blockers (nimodipine) is standard vasospasm prophylaxis. Patients are assessed daily with neurological examinations; any new deficit prompts emergency CT angiography and possible intra-arterial vasospasm therapy (balloon angioplasty or intra-arterial papaverine).

Most patients spend 2–4 weeks in hospital after ruptured aneurysm surgery and are then transferred to neurorehabilitation. Outpatient follow-up at 3 and 12 months includes CTA or MRA to confirm clip placement and exclude residual aneurysm. A DSA is recommended at 6–12 months for complex or incompletely clipped aneurysms. Neuropsychological assessment identifies cognitive difficulties — particularly in memory, attention, and executive function — that are common after SAH. Return to driving is typically allowed 3–6 months after uncomplicated surgery; contact sports and strenuous activity are restricted for 6–12 months.

In the United States, open craniotomy for cerebral aneurysm clipping costs USD 50,000–150,000 depending on urgency, hospital type, and length of ICU stay. Post-operative ICU monitoring and vasospasm management add significantly to total costs. UK private sector charges are comparable, while NHS waiting times for unruptured aneurysms can be several months.

Top-tier neurosurgical centres in India (NIMHANS Bangalore, Apollo Hospitals, Narayana Health), Thailand (Bumrungrad International), and Turkey (Acibadem Group) offer intracranial aneurysm clipping at costs of USD 8,000–22,000 — representing 70–85% savings compared with the USA. These centres are staffed by neurosurgeons with fellowship training at US and European centres, supported by neuroangiography suites, advanced IONM, and dedicated neurocritical care. Patients travelling for unruptured aneurysm treatment should plan for a 3–4 week stay including pre-operative workup, surgery, and initial recovery.

Endovascular coiling — catheter-based delivery of platinum microcoils into the aneurysm sac to induce thrombosis — is the primary alternative to open surgical clipping for most ruptured and unruptured aneurysms accessible via the ISAT-eligible anatomy. It is associated with lower short-term morbidity than open surgery but has higher recanalization rates (20–33%), requiring long-term DSA surveillance and potentially re-treatment. For wide-necked aneurysms, coiling is performed with adjunct stent or balloon remodelling techniques.

Flow diverter devices — particularly the Pipeline Embolisation Device (PED) — are used for large fusiform or giant aneurysms and have largely replaced surgical bypass for these complex lesions. They work by redirecting blood flow away from the aneurysm, inducing gradual thrombosis over weeks to months. For very small unruptured aneurysms (under 5 mm) without high-risk features in older patients, conservative management with interval imaging surveillance (annual MRA) and risk factor modification (blood pressure control, smoking cessation) may be appropriate, deferring intervention unless the aneurysm grows or changes morphology.